India easing lockdowns on cases and not vaccines risky strategy: UK study

Strategy increases chances of fresh outbreaks that would further delay economic recovery, says Oxford Economics.

Topics
Coronavirus Vaccine | New Delhi | Maharashtra

coronavirus
People visit a market that reopened on Saturday, June 18, 2021, after Delhi eased restrictions to slow down Covid-19. (PTI Photo/Arun Sharma)

The rush by India’s states to end lockdowns as new coronavirus infections drop, rather than waiting for vaccination rates to rise, risks triggering fresh restrictions and holding back the nation’s recovery, according to Oxford Economics.

“States are easing lockdowns based on lower test positivity rates rather than vaccination progress,” Priyanka Kishore, head of India and South East Asia Economics at Oxford Economics, wrote in a report to clients. “This risky strategy increases the chances of renewed outbreaks that would further delay the recovery.”

Provinces including national capital have begun reopening amid signs of infections plateauing, causing mobility rates to improve as of mid-June. While that’s likely to foster return of some demand in the near-term, there’s the risk of consumption and business activity suffering going ahead should newer restrictions be placed to control a resurgent virus wave.

With only 3.9% of India’s population fully vaccinated, Kishore sees economically important states, including and not yet reaching the “safe” levels of vaccination.

“The vaccine situation keeps our outlook cautious,” said Kishore, who maintained India’s growth forecast for this year at 9.1% -- a pace slower than the 9.5% predicted by the nation’s central bank. “Economic data also doesn’t

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Read our full coverage on Coronavirus Vaccine
First Published: Thu, June 24 2021. 10:18 IST
RECOMMENDED FOR YOU